• About us
• Contact

Advertisement

Organisation › Details

Andromeda Biotech Ltd.

Andromeda Biotech Ltd., a subsidiary of Clal Biotechnology Industries Ltd. (TASE: CBI) is focused on the development of an innovative treatment for autoimmune diabetes. Andromeda's DiaPep277®, currently in Phase III Clinical Studies, is a novel therapeutic approach to treat T1D. *

 

	Start	2007-01-01 established
	Group	Horizon Therapeutics (Group)
	Industry	DiaPep277®
	Industry 2	antidiabetic
	Person	Dagan, Shlomo (Clal 2007– CEO of Andromeda)
	Region	Yavne
	Country	Israel
	Street	42 Hayarkon Street Industrial Area
	City	81227 Yavne
	Tel	+972-8-938-7777
		Address record changed: 2020-12-02
Basic data	Employees	A: 1 to 10 (2014-04-24)
		* Document for »About Section«:
		Record changed: 2023-07-10

Advertisement

More documents for Horizon Therapeutics (Group)

• [1] Amgen Inc.. (12/12/22). "Press Release: Rule 2.7 Announcement. Amgen Inc to Acquire Horizon Therapeutics plc". Thousand Oaks, CA....
• [2] Horizon Therapeutics plc. (2/1/21). "Press Release: Horizon Therapeutics plc to Acquire Viela Bio, Inc. to Significantly Expand Development Pipeline and Grow Rare Disease Medicine Portfolio". Dublin & Gaithersburg, MD....
• [3] Horizon Therapeutics plc. (1/21/20). "Press Release: FDA Approves Tepezza (teprotumumab-trbw) for the Treatment of Thyroid Eye Disease (TED)". Dublin....
• [4] Advicenne S.A.. (1/24/18). "Press Release: Advicenne Appoints Linda Law, MD as US Vice President, Clinical Development and Medical Affairs". Nîmes....
• [5] XL-protein GmbH. (1/9/18). "Press Release: Horizon Pharma plc and XL-protein GmbH Have Entered Into a Collaboration Agreement on a Potential Next-Generation Biologic for Uncontrolled Gout Using PASylation Technology". Freising....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2024. Made in Germany.